Administration of Topical Ophthalmic Medication (ATOM): Feasibility of the spraynozzle technique.

Administration of Topical Ophthalmic Medication (ATOM): Feasibility of the spraynozzle technique. - ATOM

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON37543

Enrollment

Registered

2012-04-19

Start date

2012-07-10

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

n.v.t. onderzoek wordt verricht op gezonde vrijwilligers n.v.t.

Interventions

Topical ocular administration of fluorescein by 1) conventional eye drops in one eye versus 2) ADE Fluorescein A in the fellow eye.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Healthy volunteers with healthy eyes. Informed consent. Age > 18 years.

Exclusion criteria

Exclusion criteria: Allergy/hypersensitivity for fluorescein. Previous ocular surgery, including refractive laser surgery. Corneal condition (e.g. Sjögren, punctata). Contact lens wear. Active epithelial HSV keratitis. Pregnancy.;Concurrent use of eye drops.

Design outcomes

Primary

Measure	Time frame
Autofluorescence.	—

Secondary

Measure	Time frame
Treatment satisfaction score Blinking reflex (qualitative assessment by investigator).	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)